improved glucose tolerance in diabetic rats. Diabetes 48:2270 –2276 26.Tourrel C, Bailbe ´ D, Meile M-J, Kergoat M, Portha B 2001 Glucagon-like peptide-1 and exendin-4 stimulate /H9252-cell neogenesis in streptozotocin-treated newborn rats resulting in persistently improved glucose homeostasis at adultage. Diabetes 50:1562 –1570 27.Tourrel C, Bailbe ´ D, Lacorne M, Meile MJ, Kergoat M, Portha B 2002 Per- sistent improvement of type 2 diabetes in the Goto-Kakizaki rat model byexpansion of the beta-cell mass during the prediabetic period with glucagon-like peptide-1 or exendin-4. Diabetes 51:1443 –1452 28.Vella A, Shah P, Reed AS, Adkins AS, Basu R, Rizza RA 2002 Lack of effect of exendin-4 and glucagon-like peptide-1-(7, 36)-amide on insulin action innon-diabetic humans. Diabetologia 45:1410 –1415 29.Buse J, Fineman M, Gottlieb A, Gaines E, Kolterman O 2000 Effects of five-day dosing of synthetic exendin-4 (AC2993) in people with type 2 diabetes.Diabetes 49:A100 (Abstract)